These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 21092351)

  • 21. The assessment of changes in cognitive functioning in the elderly: age- and education-specific reliable change indices for the SIDAM.
    Stein J; Luppa M; Maier W; Tebarth F; Heser K; Scherer M; Zimmermann T; Eisele M; Bickel H; Mösch E; Weyerer S; Werle J; Pentzek M; Fuchs A; Wiese B; Prokein J; König HH; Leicht H; Riedel-Heller SG;
    Dement Geriatr Cogn Disord; 2012; 33(2-3):73-83. PubMed ID: 22414525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Routine detection and management of neurocognitive impairment in HIV-positive patients in a UK centre.
    Haddow LJ; Accoroni A; Cartledge JD; Manji H; Benn P; Gilson RJ
    Int J STD AIDS; 2013 Mar; 24(3):217-9. PubMed ID: 23535355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validation of the HIV Dementia Scale in an elderly cohort of patients with subcortical cognitive impairment caused by subcortical ischaemic vascular disease or a normal pressure hydrocephalus.
    van Harten B; Courant MN; Scheltens P; Weinstein HC
    Dement Geriatr Cogn Disord; 2004; 18(1):109-14. PubMed ID: 15087586
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnosing symptomatic HIV-associated neurocognitive disorders: self-report versus performance-based assessment of everyday functioning.
    Blackstone K; Moore DJ; Heaton RK; Franklin DR; Woods SP; Clifford DB; Collier AC; Marra CM; Gelman BB; McArthur JC; Morgello S; Simpson DM; Rivera-Mindt M; Deutsch R; Ellis RJ; Hampton Atkinson J; Grant I;
    J Int Neuropsychol Soc; 2012 Jan; 18(1):79-88. PubMed ID: 22114912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Semantic clustering inefficiency in HIV-associated dementia.
    Gongvatana A; Woods SP; Taylor MJ; Vigil O; Grant I;
    J Neuropsychiatry Clin Neurosci; 2007; 19(1):36-42. PubMed ID: 17308225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of normative neuropsychological performance in Thailand for the assessment of HIV-associated neurocognitive disorders.
    Heaps J; Valcour V; Chalermchai T; Paul R; Rattanamanee S; Siangphoe U; Sithinamsuwan P; Chairangsaris P; Nidhinandana S; Tipsuk S; Suttichom D; Fletcher J; Shikuma C; Ananworanich J
    J Clin Exp Neuropsychol; 2013; 35(1):1-8. PubMed ID: 23113809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intraindividual variability in neuropsychological performance predicts cognitive decline and death in HIV.
    Anderson AE; Jones JD; Thaler NS; Kuhn TP; Singer EJ; Hinkin CH
    Neuropsychology; 2018 Nov; 32(8):966-972. PubMed ID: 30211610
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Are MMSE and HDS-R neuropsychological tests adequate for screening HIV-associated neurocognitive disorders?
    Nakazato A; Tominaga D; Tasato D; Miyagi K; Nakamura H; Haranaga S; Higa F; Tateyama M; Fujita J
    J Infect Chemother; 2014 Mar; 20(3):217-9. PubMed ID: 24462448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Executive dysfunction and cognitive subgroups in a large sample of euthymic patients with bipolar disorder.
    Bora E; Hıdıroğlu C; Özerdem A; Kaçar ÖF; Sarısoy G; Civil Arslan F; Aydemir Ö; Cubukcuoglu Tas Z; Vahip S; Atalay A; Atasoy N; Ateşci F; Tümkaya S
    Eur Neuropsychopharmacol; 2016 Aug; 26(8):1338-47. PubMed ID: 27139077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medicalising normality? Using a simulated dataset to assess the performance of different diagnostic criteria of HIV-associated cognitive impairment.
    Underwood J; De Francesco D; Leech R; Sabin CA; Winston A;
    PLoS One; 2018; 13(4):e0194760. PubMed ID: 29641619
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical confirmation of the American Academy of Neurology algorithm for HIV-1-associated cognitive/motor disorder. The Dana Consortium on Therapy for HIV Dementia and Related Cognitive Disorders.
    Neurology; 1996 Nov; 47(5):1247-53. PubMed ID: 8909438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A preliminary evaluation of the cognitive and motor effects of pediatric HIV infection in Zairian children.
    Boivin MJ; Green SD; Davies AG; Giordani B; Mokili JK; Cutting WA
    Health Psychol; 1995 Jan; 14(1):13-21. PubMed ID: 7737068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Empiric neurocognitive performance profile discovery and interpretation in HIV infection.
    Gomez D; Power C; Gill MJ; Koenig N; Vega R; Fujiwara E
    J Neurovirol; 2019 Feb; 25(1):72-84. PubMed ID: 30519968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utility of the HIV dementia scale in assessing risk for significant HIV-related cognitive-motor deficits in a high-risk urban adult sample.
    Richardson MA; Morgan EE; Vielhauer MJ; Cuevas CA; Buondonno LM; Keane TM
    AIDS Care; 2005 Nov; 17(8):1013-21. PubMed ID: 16176897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cognitive deficits associated with human immunodeficiency virus encephalopathy.
    Krikorian R; Wrobel AJ; Meinecke C; Liang WM; Kay J
    J Neuropsychiatry Clin Neurosci; 1990; 2(3):256-60. PubMed ID: 2136083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Operationalizing and evaluating the Frascati criteria for functional decline in diagnosing HIV-associated neurocognitive disorders in adults.
    Matchanova A; Woods SP; Kordovski VM
    J Neurovirol; 2020 Apr; 26(2):155-167. PubMed ID: 31745823
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictive validity of demographically adjusted normative standards for the HIV Dementia Scale.
    Morgan EE; Woods SP; Scott JC; Childers M; Beck JM; Ellis RJ; Grant I; Heaton RK;
    J Clin Exp Neuropsychol; 2008 Jan; 30(1):83-90. PubMed ID: 17852582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is the use of the QPC cognitive complaints questionnaire relevant for the screening strategy of HIV-Associated neurocognitive disorders?
    Zaegel-Faucher O; Laroche H; Tixier M; Morisseau V; Obry-Roguet V; Poizot-Martin I
    AIDS Care; 2021 Mar; 33(3):389-397. PubMed ID: 32279542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New DSM-V neurocognitive disorders criteria and their impact on diagnostic classifications of mild cognitive impairment and dementia in a memory clinic setting.
    Tay L; Lim WS; Chan M; Ali N; Mahanum S; Chew P; Lim J; Chong MS
    Am J Geriatr Psychiatry; 2015 Aug; 23(8):768-79. PubMed ID: 25728011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A multimodal assessment of driving performance in HIV infection.
    Marcotte TD; Wolfson T; Rosenthal TJ; Heaton RK; Gonzalez R; Ellis RJ; Grant I;
    Neurology; 2004 Oct; 63(8):1417-22. PubMed ID: 15505158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.